Title

Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis.

Document Type

Article

Publication Date

1-1-2018

Publication Title

Case Rep Gastrointest Med

Abstract

Outcome data regarding the use of tumor necrosis factor alpha inhibitors (anti-TNFα) in patients with inflammatory bowel disease (IBD) after liver transplant (LT) for primary sclerosing cholangitis (PSC) are scant.

PubMed ID

29862092

Volume

2018

First Page

1015408

Share

COinS